Mycophenolate Mofetil Improves Exercise Tolerance in Systemic Sclerosis Patients with Interstitial Lung Disease: A Pilot Study.
Valentina VaiarelloStefano SchiavettoFederica FotiAntonietta GiganteFrancesco IannazzoGregorino PaonePaolo PalangeEdoardo RosatoPublished in: Rheumatology and therapy (2020)
These data from our pilot study on a small cohort of SSc patients are the first to demonstrate that treatment with MMF can improves exercise tolerance and leg discomfort in patients with SSc-ILD. These preliminary results need to be confirmed in large randomized studies.
Keyphrases
- interstitial lung disease
- systemic sclerosis
- rheumatoid arthritis
- end stage renal disease
- idiopathic pulmonary fibrosis
- high intensity
- ejection fraction
- chronic kidney disease
- newly diagnosed
- physical activity
- open label
- double blind
- prognostic factors
- electronic health record
- machine learning
- placebo controlled
- big data
- deep learning